These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3682505)

  • 1. [Urinary low molecular promoter of calcium oxalate monohydrate crystal aggregation, preliminary report].
    Shirane Y; Hiraishi K; Kurokawa K
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1149-54. PubMed ID: 3682505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary material affecting calcium oxalate monohydrate stone formation].
    Shirane Y; Yamamoto A; Mizuta K; Hiraishi K; Kurokawa K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):995-9. PubMed ID: 2607720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Rattan V; Thind SK; Nath R; Malakondaiah GC; Tandon SP
    Indian J Med Res; 1987 Oct; 86():500-5. PubMed ID: 3443483
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycose aminoglycane excretion and concentration in the urine of patients with frequently recurrent calcium-oxalate lithiasis prior to and following Diclofenac-Na therapy.
    Brundig P; Börner RH; Haerting R; Janitzky V; Schlichter A
    Urol Res; 1990; 18(1):21-4. PubMed ID: 2316068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of calcium oxalate crystalluria by infrared analysis].
    Tozuka K; Moriguchi H; Hara Y; Goto K; Tokue A
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1669-72. PubMed ID: 3251102
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
    Scurr DS; Latif AB; Sergeant V; Robertson WG
    Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis.
    Galán JA; Conte A; Llobera A; Costa-Bauzá A; Grases F
    Urol Int; 1996; 56(2):79-85. PubMed ID: 8659015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High molecular weight substances which inhibit calcium oxalate crystal growth. 4: Studies on the role of urinary pepsinogen and mucopolysaccharide as inhibitors of calcium oxalate crystal growth (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1355-9. PubMed ID: 153421
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of calcium phosphate crystalluria: influence of pH and osmolality and invariable presence of oxalate.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):458-62. PubMed ID: 2611613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.